Biopharmaceuticals

A Global Strategic Business Report

MCP-7003

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

15662

EXECUTIVE POOL

5850

PRICE

1566

EXPERT INPUTS

214

COMPANIES

103

DATA TABLES

262

PAGES

18

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (82838)

2571

CXO

5724

VICE PRESIDENT

33612

DIRECTOR

30302

MANAGER

10629

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Biopharmaceuticals Market to Reach US$882.9 Billion by 2030

The global market for Biopharmaceuticals estimated at US$443.8 Billion in the year 2024, is expected to reach US$882.9 Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2024-2030. Monoclonal Antibody, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$288.2 Billion by the end of the analysis period. Growth in the Erythropoietin segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$119.9 Billion While China is Forecast to Grow at 16.1% CAGR

The Biopharmaceuticals market in the U.S. is estimated at US$119.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$188.6 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Biopharmaceuticals Market - Key Trends and Drivers Summarized

Biopharmaceuticals, a dynamic intersection of biotechnology and pharmaceutical manufacturing, are revolutionizing modern medicine by offering targeted treatments for severe health conditions such as cancer, diabetes, cardiovascular diseases, and immune disorders. These drugs, composed of proteins, sugars, nucleic acids like DNA and RNA, or a combination thereof, are derived from living organisms, including humans, animals, plants, fungi, and microbes. What distinguishes biopharmaceuticals is their structural similarity to naturally occurring compounds in the body, which enhances their effectiveness and integration into biological processes. This alignment allows for more precise targeting of diseased cells, resulting in improved therapeutic outcomes and reduced side effects. Biopharmaceutical production involves advanced genetic techniques, including the creation of recombinant proteins and the use of stem cells and blood components, showcasing the field`s versatility and potential.

The biopharmaceutical industry offers several advantages over traditional pharmaceuticals. Biopharmaceuticals can lower overall healthcare costs by improving the quality of life and extending life expectancy for patients with complex diseases and rare disorders. Their targeted approach typically results in fewer side effects compared to conventional drugs, which often affect multiple body systems. The rise of biopharmaceuticals aligns with the increasing demand for personalized medicine, enabled by technological advancements that provide deeper insights throughout the drug development process. Companies are adopting data-driven approaches, leveraging machine learning and artificial intelligence to analyze vast datasets, better understand drug-disease interactions, and optimize research and development strategies. This shift towards precision medicine is driving the creation of more effective, tailored treatments and positioning biopharmaceuticals at the forefront of medical innovation.

The biopharmaceutical market`s growth is driven by several key factors. Advanced simulation software and precision modeling tools like GastroPlus® and ADMET Predictor enhance early drug development by predicting human pharmacokinetics and minimizing late-stage failures. High-throughput screening technologies facilitate the rapid assessment of numerous drug candidates, streamlining the selection process. Nanotechnology plays a crucial role in enhancing the bioavailability of poorly soluble and permeable drugs, expanding the range of viable compounds. The trend towards patient-centric drug development supports personalized medicine, optimizing treatments for specific patient subgroups and improving compliance. Regulatory support, such as the Biopharmaceutics Classification System (BCS) and the Developability Classification System (DCS), streamlines approvals and reduces development costs by waiving certain clinical studies. The integration of digital health technologies, such as smart drug delivery systems, allows for real-time monitoring and dynamic dosing adjustments, enhancing patient management. Additionally, environmental sustainability is becoming increasingly important, with biopharmaceutics contributing to greener pharmaceutical practices by optimizing formulations to reduce waste and improve efficiency.

As biopharmaceuticals continue to evolve, they promise to transform treatment paradigms globally, offering more personalized, effective healthcare solutions. The industry`s focus on targeted therapies tailored to individual genetic profiles heralds a future where diseases that are currently difficult to manage become more controllable and treatable. The continuous advancement in biopharmaceutical technology, coupled with a growing emphasis on personalized medicine, positions the sector for significant growth and impact, benefiting billions of people worldwide. This ongoing evolution underscores the importance of biopharmaceuticals in advancing healthcare, driving innovation, and improving patient outcomes across a wide range of medical conditions.

SCOPE OF STUDY

The report analyzes the Biopharmaceuticals market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone, Other Types); Application (Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease, Other Applications).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Abbott Diagnostics, Inc. - Core Laboratory; Amgen, Inc.; Biogen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novo Nordisk A/S; Pfizer, Inc.; Sanofi

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Biopharmaceuticals – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 214 Players Worldwide in 2024 (E)

Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Prevalence of Chronic Diseases Drives Growth in Biopharmaceuticals Market

Advances in Biotechnology Propel Market Expansion

Growing Focus on Personalized Medicine Expands Addressable Market Opportunities

Rising Adoption of Biologic Drugs Strengthens Business Case for Biopharmaceuticals

Integration with Advanced Drug Delivery Systems Generates Demand for Biopharmaceuticals

Technological Innovations in Genetic Engineering Propel Market Growth

Increasing Use of Biopharmaceuticals in Oncology Spurs Market Expansion

Advances in Monoclonal Antibodies Enhance Demand for Biopharmaceuticals

Growing Focus on Biosimilars Expands Market Opportunities

Rising Demand for Targeted Therapies Drives Adoption of Biopharmaceuticals

Advances in Cell and Gene Therapies Propel Growth in Biopharmaceuticals Market

Increasing Regulatory Approvals for Biopharmaceuticals Generate Market Demand

Technological Innovations in Bioprocessing Propel Market Expansion

Growing Use of Biopharmaceuticals in Rare Diseases Spurs Market Growth

Rising Investment in Research and Development Expands Addressable Market for Biopharmaceuticals

Focus on Reducing Healthcare Costs Drives Adoption of Biopharmaceutical Solutions

4. GLOBAL MARKET PERSPECTIVE

World Recent Past, Current & Future Analysis for Monoclonal Antibody by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Monoclonal Antibody by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Monoclonal Antibody by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Erythropoietin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Erythropoietin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Erythropoietin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Insulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Insulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Insulin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Interferon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Interferon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Interferon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Growth & Coagulation Factor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Growth & Coagulation Factor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Growth & Coagulation Factor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hormone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Blood Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Blood Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Blood Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Cardiovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Metabolic Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Metabolic Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Metabolic Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Neurological Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Neurological Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Neurological Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Biopharmaceuticals Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

JAPAN

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

CHINA

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

EUROPE

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Biopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

FRANCE

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

GERMANY

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

UNITED KINGDOM

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Biopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

AUSTRALIA

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

INDIA

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

LATIN AMERICA

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Biopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

MIDDLE EAST

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Biopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

AFRICA

Biopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Biopharmaceuticals by Type - Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Biopharmaceuticals by Type - Percentage Breakdown of Value Sales for Monoclonal Antibody, Erythropoietin, Insulin, Vaccine, Interferon, Growth & Coagulation Factor, Hormone and Other Types for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Biopharmaceuticals by Application - Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Biopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Blood Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology, Neurological Disease and Other Applications for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
2A Pharma	%
3P Biopharmaceuticals	%
3SBio, Inc.	%
89bio	%
Abaxys Therapeutics SA	%
Abbott Laboratories, Inc.	%
AbbVie, Inc.	%
AbCheck s.r.o.	%
Abilita Bio, Inc.	%
Abion Bio	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll